Human Aggrecan core protein(AGC1) ELISA kit

Code CSB-EL001440HU
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified by monoclonal antibody A0122)
Alternative Names
ACAN ELISA Kit; AGC1 ELISA Kit; CSPG1 ELISA Kit; MSK16 ELISA Kit; Aggrecan core protein ELISA Kit; Cartilage-specific proteoglycan core protein ELISA Kit; CSPCP ELISA Kit; Chondroitin sulfate proteoglycan core protein 1 ELISA Kit; Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2] ELISA Kit
Abbreviation
AGC1
Uniprot No.
Species
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates
Detection Range
0.156 ng/mL-10 ng/mL
Sensitivity
0.039 ng/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Signal Transduction
Assay Principle
quantitative
Measurement
Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human AGC1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
  Sample Serum(n=4)
1:5 Average % 89
Range % 83-94
1:10 Average % 100
Range % 95-105
1:20 Average % 107
Range % 103-110
1:40 Average % 89
Range % 85-91
Recovery
The recovery of human AGC1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range
Serum (n=5) 105 100-110
EDTA plasma (n=4) 88 83-95
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
ng/ml OD1 OD2 Average Corrected
10 2.484 2.431 2.458 2.281
5 2.068 2.104 2.086 1.909
2.5 1.410 1.500 1.455 1.278
1.25 0.783 0.798 0.791 0.614
0.625 0.484 0.501 0.493 0.316
0.312 0.342 0.335 0.339 0.162
0.156 0.239 0.241 0.240 0.063
0 0.178 0.176 0.177  
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Human AGC1 ELISA Kit was designed for the quantitative measurement of Human AGC1 protein in serum, plasma, tissue homogenates. It is a Sandwich ELISA kit, its detection range is 0.156 ng/mL-10 ng/mL and the sensitivity is 0.039 ng/mL.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
This proteoglycan is a major component of extracellular matrix of cartilagenous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region.
Gene References into Functions
  1. Reciprocal translocation t(10;15)(q22.3;q26.1) interrupting ACAN gene is associated with short stature. PMID: 29302920
  2. genetic association studies in pediatric population in Japan: Data suggest that mutations in ACAN (aggrecan), FGFR3 (fibroblast growth factor receptor-3), or GHRHR (growth- hormone-releasing-hormone receptor) are associated with idiopathic short stature in the population studied. PMID: 28768959
  3. In bicuspid aortic valve disease, there was a significant reduction of aggrecan expression in bicuspid aortic valve. PMID: 28986054
  4. Overexpression of miR-3150a-3p decreased ACAN expression in nucleus pulposus cells, whereas inhibition of miR-3150a-3p increased ACAN expression. In addition, ACAN expression was negatively correlated with intervertebral disc degeneration (IDD) grade. The reduction of ACAN expression induced by the upregulation of miR-3150a-3p might participate in the development of IDD. PMID: 29554650
  5. Our study demonstrated that altered levels of ADAMTS-1 and aggrecan may have a partial role in the etiopathogenesis of Polycystic ovary syndrome (PCOS), and ADAMTS-1 could be a predictive marker for implantation success in PCOS patients. PMID: 28417352
  6. ACAN mutation is a relative common cause of familial severe short stature PMID: 28396070
  7. Chondrogenic potential was higher and Wnt/beta-catenin signaling was more potently activated by a GSK-3beta inhibitor in the posterior than in the anterior part of the human infant sclera. PMID: 27336854
  8. single nucleotide variants of ACAN and their haplotypes are associated with the severity of lumbar disc herniation. PMID: 28742099
  9. Four of 29 small for gestational age children with advanced bone age had an ACAN gene mutation (13.8%). Mutations were related to additional characteristics: midface hypoplasia, joint problems, and broad great toes. PMID: 27710243
  10. SNVs of candidate genes in ACAN metabolic pathway are associated with severity of Lumbar disc degeneration and Modic changes in patients with chronic mechanical low back pain. PMID: 28081267
  11. Heterozygous aggrecan mutations result in a phenotypic spectrum ranging from mild and proportionate short stature to a mild skeletal dysplasia with disproportionate short stature and brachydactyly. PMID: 27870580
  12. deacetylation promotes SOX9 nuclear translocation and hence its ability to activate ACAN. PMID: 26910618
  13. Femoral and tibial cartilage show a different behaviour concerning expression values for the genes Col1A1, Col2A1 and Agg. PMID: 28302318
  14. The genotype and allele frequencies of the COL2A1 genetic polymorphisms (rs1793953 and rs2276454) and the Aggrecan VNTR polymorphisms differed significantly between the case group and the control group.the genotype and allele frequencies of the COL2A1 genes, rs1793953 and rs2276454, and Aggrecan VNTR significantly differed in terms of Pfirrmann grades III, IV, and V PMID: 27991836
  15. Decrease in mRNA expression of ACAN is associated with Osteoarthritis. PMID: 27428952
  16. Results showed an association between short alleles and lumbar disc herniation (LDH), corroborating the hypothesis that aggrecan with shorter repeat lengths can lead to a reduction in the physiological proteoglycan function of intervertebral disc hydration and, consequently, increased individual susceptibility to LDH. PMID: 28002585
  17. Citrullinated Proteoglycan Aggrecan is a new member of citrullinated proteins identified in human joints. PMID: 26943656
  18. Idiopathic short stature is due to novel heterozygous mutation of the aggrecan gene. PMID: 25741789
  19. Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing. PMID: 25715982
  20. ACAN positive perineuronal nets and glial cells were decreased in the amygdala of szhizophrenia and bipolar disorder patients compared to controls. PMID: 25603412
  21. An underlying interaction between aggrecan VNTR and obesity in symptomatic lumbar disc herniation. PMID: 25188217
  22. The results suggest that regions within ACAN is associated with ACL injury susceptibility and that genetic sequence variability within genes encoding proteoglycans may potentially modulate the ligament fibril properties. PMID: 24552666
  23. results suggested that genetic variants in ACAN and MET are associated with HM. Functional roles of ACAN and MET in the development of HM need to be further investigated PMID: 24766640
  24. Data show there was no significant difference in the aggrecan (ACAN) rs1516797 genotype or allele distributions between the carpal tunnel syndrome (CTS) and control groups. PMID: 25173489
  25. Heterozygous mutations in ACAN can cause a mild skeletal dysplasia, which presents clinically as short stature with advanced bone age. PMID: 24762113
  26. ROCKi decreased the association between ETS-1 and its binding sites on the MMP-3 promoter, whereas ROCKi promoted the interaction between SOX9 and the AGN promoter. PMID: 24111521
  27. SHOX2, like SHOX, regulates NPPB directly whilst activates ACAN via its cooperation with the SOX trio. PMID: 24421874
  28. microRNA-140 targets RALA and regulates chondrogenic differentiation of human mesenchymal stem cells by translational enhancement of SOX9 and ACAN. PMID: 24063364
  29. significant increased risks were found among Asians with shorter alleles of Aggrecan PMID: 24296484
  30. PKCepsilon activation in late passage NP cells may represent a molecular basis for aggrecan availability, as part of an PKCepsilon/ERK/CREB/AP-1-dependent transcriptional program that includes upregulation of both chondrogenic genes and microRNAs PMID: 24312401
  31. The expression of growth differentiation factor 5 (GDF5) and aggrecan in 15 cases of salivary gland pleomorphic adenomas, was investigated. PMID: 24398992
  32. Data indicate link protein peptide (LPP) upregulates expression of aggrecan and collagen II at both mRNA and protein levels. PMID: 23370687
  33. the subsequent presentation of aggregan from ECM leads to CD4(+) T-cell activation and effector cell formation. PMID: 24032649
  34. ADAMTS-4_v1 is expressed as a protein in vivo in human osteoarthritis synovium, functions as an aggrecanase, and cleaves other proteoglycan substrates. PMID: 23897278
  35. The total mole fraction of unelongated xylose residues per aggrecan was significantly less (p = 0.03) after IL-1beta treatment compared to control cultures. PMID: 23237500
  36. aggrecan alleles with shorter VNTR length have a role in intervertebral disc degeneration, while VDR (TaqI, FokI, ApaI) gene polymorphisms do not [meta-analysis] PMID: 23209686
  37. The concentration of aggrecan, biglycan, and decorin was determined in six regions of the human supraspinatus tendon. PMID: 22329809
  38. The reduction in keratan sulfate levels and the strong correlation between chondroitin 6-sulfate and keratan sulfate levels indi-cates suppressed cartilage turnover after arthroscopic surgery. PMID: 22441960
  39. Identification of enhancer sequences involved in the regulation of expression of the human ACAN gene. PMID: 22820679
  40. Data suggest that matrix metalloproteinases are mainly involved in normal aggrecan turnover in extracellular matrix and may have less-active roles in aggrecan degradation during knee injury or osteoarthritis (where aggrecanase-1 has central role). PMID: 22670872
  41. In the CNS, aggrecan is expressed in a precise and tightly regulated manner both temporally and spatially. (Review) PMID: 22297263
  42. Increased expression of collagen II, aggrecan, and cartilage oligomeric matrix protein (COMP), were observed during differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes. PMID: 22241609
  43. Yiqi Huayu Bushen Recipe increased the expression of aggrecan, decreased the expression of type X collagen, and promoted cell proliferation in cells from degenerated human intervertebral discs. PMID: 22015197
  44. In Turkish population, short repeated alleles of the aggrecan gene are associated with increased disc degeneration and disc herniation. PMID: 21948754
  45. Data show that a molecular complex of fibronectin and aggrecan predicts response to lumbar ESI for radiculopathic back pain with HNP. PMID: 21224775
  46. in the human cerebral cortex, discrete, layer-specific PNNs are assembled through the participation of selected aggrecan isoforms that characterize defined subsets of cortical neurons PMID: 19220578
  47. The objective of the present study was to assess the immunolocalization of aggrecan in the annulus, and to assess molecular gene expression patterns in the annulus extracellular matrix. PMID: 21689646
  48. Carrying a copy of the aggrecan allele with 21 repeats may increase the risk of multiple disc degeneration in subjects less than 40 years of age. PMID: 20936487
  49. This study tests the hypothesis that disease severity is characterized by alterations in expression of cartilage-specific genes for aggrecan and collagen type II. PMID: 21655647
  50. Confocal immunostaining demonstrated colocalization of m-calpain and the aggrecan product within the lower hypertrophic chondrocytes and in limited region of the pericellular matrix. PMID: 21117903

Show More

Hide All

Involvement in disease
Spondyloepiphyseal dysplasia type Kimberley (SEDK); Spondyloepimetaphyseal dysplasia, aggrecan type (SEMDAG); Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans (SSOAOD)
Subcellular Location
Secreted, extracellular space, extracellular matrix.
Protein Families
Aggrecan/versican proteoglycan family
Tissue Specificity
Restricted to cartilages.
Database Links

HGNC: 319

OMIM: 155760

KEGG: hsa:176

UniGene: Hs.2159

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1